Speakers
David Chen
Managing Director
BFC Group
Toby Freyman
Vice President, Business Development
Alexion Pharmaceuticals
Dan Zheng
Senior Director for Oncology Business Development,Center for External Innovation
Takeda
Christopher Hupp
Senior Director, External Innovation
Chemistry, Ipsen
Maha Radhakrishnan
Executive Partner
Sofinnova Investments
Grace Han McMahon
Associate Vice President and Head, Pacific Business Development & Licensing
MSD
Harish Soundararajan
Vice President
Roivant Sciences
Johan Verbeeck
Vice President Business Development
Johnson & Johnson Innovative Medicine
Mitchell Zhang
Vice President
BFC Group
Henry He
Partner
Fangda Partners
Adrianne L.Wong
Director, Oncology Search & Evaluation of Global Business Development
Daiichi Sankyo
Michael Tung
MD, Chief Financial Officer
vTv Therapeutics
Yuan Mi
Founder/COO
CytosinLab Therapeutics
Tess Cameron
Principal
RA Capital
Venkatesan Raghavan
Executive Director Search & Evaluation – Oncology
Novartis
René Fuertig
Global Head of Neuroscience & Mental Health BD+L
Boehringer Ingelheim
Guoxin Zhu
Vice President, Molecule Discovery, Lilly Research Laboratories
Eli Lilly and Company
Tomohiro Yamauchi
Executive Director, Global Head of Scouting & Transaction Oncology
Astellas
Josh Shin
Partner
Fangda Partners
Cynthia Wang
Director, Global Business Development, Asia-Pacific Region
Servier
Register
Brochure